Denali Therapeutics Inc. DNLI Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $3.04B.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s market capitalization?
- Denali Therapeutics Inc. (DNLI) reported market capitalization of $3.04B in Q1 2026.
- How has Denali Therapeutics Inc.'s market capitalization changed year-over-year?
- Denali Therapeutics Inc.'s market capitalization increased by 54.2% year-over-year, from $1.97B to $3.04B.
- What is the long-term trend for Denali Therapeutics Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s market capitalization has grown at a -24.1% compound annual growth rate (CAGR), from $10.23B to $2.58B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.